Elixir, a subsidiary of Rite Aid, launched a specialty generic medication enhancement to its managed copay solutions that allow members to receive generic versions of certain specialty medications at ...
The word "elixir" comes from Greek origin of "powder for drying wounds". Its modern definition means a clear, sweet-flavored liquid medication. However, the case of Elixir Sulfanilamide, a poisonous ...
Initial Clinical Findings to be presented at TCT 2011 Satellite Symposium Sunnyvale, CA —Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced ...
SUNNYVALE, Calif. & WASHINGTON--(BUSINESS WIRE)--October 16, 2008--Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, ...
Rite Aid’s pharmacy benefits subsidiary Elixir has a new face in its c-suite. Lance Neill is joining the company as COO following his most recent role as Centene’s vice president of network ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--Marking a milestone in the evolution of fully-bioresorbable drug-eluting scaffolds for interventional cardiology, the first commercial implant of Elixir Medical's ...
Elixir Medical Announces Excellent Six-Month Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System at Late Breaking Clinical Trial ...
> Elixir Pharmaceuticals and Siena Biotech have entered into an agreement to collaborate on the optimization, validation and evaluation of Elixir's SIRT1 inhibitors in Huntington's disease. Release > ...
PARIS--(BUSINESS WIRE)--Elixir Medical, a developer of breakthrough cardiovascular technologies, today announced that the large international randomized BIOADAPTOR RCT trial of the company’s DynamX ® ...
Phenobarbital 16.2mg, hyoscyamine sulfate 0.1037mg, atropine sulfate 0.0194mg, scopolamine HBr 0.0065mg; per 5mL; contains alcohol; grape flavor. <10lb (4.5kg): not ...
Nov 19 (Reuters) - Elixir Pharmaceuticals Inc said a late-stage trial of its oral formulation for diabetes met the main goal of the study. Patients receiving a combination of mitiglinide and metformin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback